These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 23298185

  • 1. The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells.
    Brett A, Pandey S, Fraizer G.
    Mol Cancer; 2013 Jan 08; 12():3. PubMed ID: 23298185
    [Abstract] [Full Text] [Related]

  • 2. Wilms' tumor 1 (WT1) promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling.
    Han Y, Song C, Zhang T, Zhou Q, Zhang X, Wang J, Xu B, Zhang X, Liu X, Ying X.
    Cell Cycle; 2020 Oct 08; 19(20):2662-2675. PubMed ID: 32892698
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W, Wang L, Mizokami A, Shi J, Zou C, Dai J, Keller ET, Lu Y, Zhang J.
    Chin J Cancer; 2017 Mar 29; 36(1):35. PubMed ID: 28356132
    [Abstract] [Full Text] [Related]

  • 5. Transcriptional regulation of the human thromboxane A2 receptor gene by Wilms' tumor (WT)1 and hypermethylated in cancer (HIC) 1 in prostate and breast cancers.
    Keating GL, Reid HM, Eivers SB, Mulvaney EP, Kinsella BT.
    Biochim Biophys Acta; 2014 Jun 29; 1839(6):476-92. PubMed ID: 24747176
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
    Chen J, Gao S, Wang C, Wang Z, Zhang H, Huang K, Zhou B, Li H, Yu Z, Wu J, Chen C.
    J Exp Clin Cancer Res; 2016 Nov 07; 35(1):173. PubMed ID: 27821145
    [Abstract] [Full Text] [Related]

  • 8. Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer.
    Eisermann K, Tandon S, Bazarov A, Brett A, Fraizer G, Piontkivska H.
    BMC Genomics; 2008 Jul 16; 9():337. PubMed ID: 18631392
    [Abstract] [Full Text] [Related]

  • 9. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.
    Damon SE, Plymate SR, Carroll JM, Sprenger CC, Dechsukhum C, Ware JL, Roberts CT.
    Endocrinology; 2001 Jan 16; 142(1):21-7. PubMed ID: 11145562
    [Abstract] [Full Text] [Related]

  • 10. The Wilms' tumor suppressor Wt1 activates transcription of the erythropoietin receptor in hematopoietic progenitor cells.
    Kirschner KM, Hagen P, Hussels CS, Ballmaier M, Scholz H, Dame C.
    FASEB J; 2008 Aug 16; 22(8):2690-701. PubMed ID: 18424770
    [Abstract] [Full Text] [Related]

  • 11. Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter.
    Cheema SK, Mishra SK, Rangnekar VM, Tari AM, Kumar R, Lopez-Berestein G.
    J Biol Chem; 2003 May 30; 278(22):19995-20005. PubMed ID: 12644474
    [Abstract] [Full Text] [Related]

  • 12. The transcription factor sterile alpha motif (SAM) pointed domain-containing ETS transcription factor (SPDEF) is required for E-cadherin expression in prostate cancer cells.
    Pal M, Koul S, Koul HK.
    J Biol Chem; 2013 Apr 26; 288(17):12222-31. PubMed ID: 23449978
    [Abstract] [Full Text] [Related]

  • 13. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
    Fraizer G, Leahy R, Priyadarshini S, Graham K, Delacerda J, Diaz M.
    Int J Oncol; 2004 Mar 26; 24(3):461-71. PubMed ID: 14767530
    [Abstract] [Full Text] [Related]

  • 14. Wilms' tumour protein Wt1 stimulates transcription of the gene encoding vascular endothelial cadherin.
    Kirschner KM, Sciesielski LK, Scholz H.
    Pflugers Arch; 2010 Nov 26; 460(6):1051-61. PubMed ID: 20811903
    [Abstract] [Full Text] [Related]

  • 15. Renal carcinoma-associated transcription factors TFE3 and TFEB are leukemia inhibitory factor-responsive transcription activators of E-cadherin.
    Huan C, Sashital D, Hailemariam T, Kelly ML, Roman CA.
    J Biol Chem; 2005 Aug 26; 280(34):30225-35. PubMed ID: 15994295
    [Abstract] [Full Text] [Related]

  • 16. Cadherins in Wilms' tumor: E-cadherin expression despite absence of WT1.
    Baudry D, Cabanis MO, Patte C, Zucker JM, Pein F, Fournet JC, Sarnacki S, Junien C, Jeanpierre C.
    Anticancer Res; 2003 Aug 26; 23(1A):475-8. PubMed ID: 12680252
    [Abstract] [Full Text] [Related]

  • 17. RNA-Sequencing Analysis Indicates That N-Cadherin Promotes Prostate Cancer Progression by the Epigenetic Modification of Key Genes.
    Quan Y, Ping H, Wang M, Zhang X.
    DNA Cell Biol; 2023 Sep 26; 42(9):563-577. PubMed ID: 37540080
    [Abstract] [Full Text] [Related]

  • 18. VEGF transcription and mRNA stability are altered by WT1 not DDS(R384W) expression in LNCaP cells.
    Cash J, Korchnak A, Gorman J, Tandon Y, Fraizer G.
    Oncol Rep; 2007 Jun 26; 17(6):1413-9. PubMed ID: 17487399
    [Abstract] [Full Text] [Related]

  • 19. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
    Vidovic K, Svensson E, Nilsson B, Thuresson B, Olofsson T, Lennartsson A, Gullberg U.
    Leukemia; 2010 May 26; 24(5):992-1000. PubMed ID: 20237505
    [Abstract] [Full Text] [Related]

  • 20. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y, Cui Z, Li X, Jin X, Peng J.
    Oncotarget; 2017 Apr 18; 8(16):26090-26099. PubMed ID: 28212533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.